Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Freenome Holdings Inc (Freenome) develops and provides a medical artificial intelligence (AI) platform which to detect cancer at its earliest stages. The company provides cell-free (cf) biomarkers which include cfDNA, Provides insights into immune response and tumor heterogeneity, cfRNA, Records which genes were actively expressed at the time of apoptosis, and Proteins, Identifies proteins associated with specific tumor types. Freenome is utilizing an AI genomics platform and developing noninvasive blood tests to detect early-stage cancer and improve precision oncology treatments. The company collaborated with pharmaceutical companies, integrated health systems and academic institutions to use its AI genomics platform for improving cancer treatment. Freenome is headquartered in South San Francisco, California, the US.

Gain a 360-degree view of Freenome Inc and make more informed decisions for your business Gain a 360-degree view of Freenome Inc and make more informed decisions for your business Register your interest
Headquarters United States of America

Address 5th Floor, 259 East Grand Avenue, San Francisco, California, 94080


Industry Medical Equipment

   

   

Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Freenome Inc premium industry data and analytics

5

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

5

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

Products and Services

Products Services Brands
Technology Platform: Multiomics Platform Services Freenome
Multiomics Platform Early Cancer Detection Blood Tests
Understand Freenome Inc portfolio and identify potential areas for collaboration Understand Freenome Inc portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters Freenome Inc Exosome Diagnostics Inc Genomic Health Inc Genomic Expression Inc
Headquarters United States of America United States of America United States of America United States of America
City San Francisco Waltham Redwood City New York City
State/Province California Massachusetts California New York
No. of Employees - - - -
Entity Type Private Private Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Executives
Name Position Board Since Age
Aaron Elliott, Ph.D Chief Executive Officer Senior Management 2025 -
Linh H. Le Chief Financial Officer Senior Management 2025 -
Julie Tran Chief People Officer Senior Management - -
Lance Baldo Chief Medical Officer Senior Management - -
Jimmy Lin Chief Scientific Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Freenome Inc key executives to enhance your sales strategy Gain insight into Freenome Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?